Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: Comparison between different European regions

Citation
M. Toeller et al., Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: Comparison between different European regions, HORMONE MET, 31(12), 1999, pp. 680-685
Citations number
29
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
HORMONE AND METABOLIC RESEARCH
ISSN journal
00185043 → ACNP
Volume
31
Issue
12
Year of publication
1999
Pages
680 - 685
Database
ISI
SICI code
0018-5043(199912)31:12<680:POCCMC>2.0.ZU;2-Z
Abstract
This study compares the prevalence of chronic complications, the quality of metabolic control and the nutritional intake in people with type 1 diabete s in different European regions. The EURODIAB Complications Study included a sample of 3250 European patients with type 1 diabetes stratified for gend er, age and diabetes duration. All examinations were performed using standa rdised, validated methods. HBA1c, LDL-cholesterol and fasting triglycerides were higher in the eastern European centres than in the southern or north- western European centres. Acute (severe ketoacidosis, severe hypoglycaemia) and chronic diabetes complications (retinopathy, nephropathy, neuropathy, cardiovascular disease) were all considerably more frequent in the eastern European centres. HbA1c was lower in the German centres than in the total E URODIAB cohort or in the north-western European centres, but severe hypogly caemia and proliferative retinopathy were more common. Persons from the eas tern European and the German centres consumed undesirably high amounts of c holesterol, total and saturated fat. Overall, improvements in the preventio n, detection and management of diabetes complications in persons with type 1 diabetes are essential throughout Europe, particularly in eastern Europea n regions. Since elevated LDL-cholesterol levels and hypertension were stri kingly common in this relatively young cohort of European people with type 1 diabetes, generally more attention should be directed towards an adequate management of these cardiovascular risk factors.